Influenza

Plant-Based Vaccine Manufacturing for Influenza, Implications for Future Vaccines

By

Tori Rodriguez, MA, LPC, AHC

An emerging body of research highlights plant-based vaccine manufacturing as a potential solution to risks posed by traditional egg-based manufacturing.

How to Prepare Patients for the New Influenza Season During COVID-19 Pandemic

By

Jessica Kovalchick, RPA-C

The Advisory Committee on Immunization Practices encourages all Americans to receive the flu vaccine between September and October.

Overcoming Challenges to Create a Universal Influenza Vaccine

By

Jasenka Piljac Žegarac, PhD

Researchers from the National Institute of Allergy and Infectious Diseases are working to develop a universal influenza vaccine.

FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV

By

Brian Park, PharmD

The test is the first non-prescription multi-analyte COVID-19 test that allows individuals to test nasal swab samples self-collected at home.

Concomitant Flu Vaccine, COVID-19 Booster in Older Adults: Safety, Immunogenicity

By

Pam Brick

A phase 2 study assessed safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine with a mRNA-1273 vaccine booster dose in older adults.

Effect of Baloxavir Marboxil vs Oseltamivir on Familial Influenza Transmission

By

Virginia A. Schad, PharmD, RPh

Researchers compared the incidence of intra-familial influenza transmission after treatment of the first family member with baloxavir marboxil vs oseltamivir.

Coadministration of QIV-HD Influenza Vaccine, mRNA-1273 COVID-19 Vaccine Is Safe

By

Sheila Jacobs

Researchers examined the safety and immunogenicity of administering a high-dose quadrivalent influenza vaccine and a third dose of mRNA-1273 vaccine booster concomitantly.

Bird Flu Sweeping Through Poultry in Eastern US

Mass culling has been implemented as a highly contagious form of avian flu has swept across the eastern half of the United States in recent weeks.

New Tool Predicts Need for Invasive Ventilation in Flu-Related Pneumonia

By

Pam Brick

A new assessment tool predicts the need for invasive mechanical ventilation in patients with influenza-related pneumonia within 14 days of admission.

Do Influenza Vaccines That Are Mismatched to Flu Viruses Protect Children?

By

Ron Goldberg

How well do influenza vaccines protect children against critical and life-threatening illness when vaccines are mismatched with the virus?

Flu Vaccine Effective Against Life-Threatening Illness in Children

Vaccine effectiveness 75 percent during 2019 to 2020 season, when vaccine-mismatched viruses predominated